Williams-Sonoma: Q1 Earnings Insights

Williams-Sonoma (NYSE:WSM) reported its Q1 earnings results on Tuesday, May 23, 2023 at 09:00 AM. Here’s what investors…

Williams-Sonoma (NYSE:WSM) reported its Q1 earnings results on Tuesday, May 23, 2023 at 09:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Williams-Sonoma beat estimated earnings by 11.39%, reporting an EPS of $2.64 versus an estimate of $2.37.

Revenue was down $116.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 2.58% drop in the share price the next day.

Here’s a look at Williams-Sonoma’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 5.46 3.71 3.49 2.88
EPS Actual 5.50 3.72 3.87 3.50
Revenue Estimate 2.60B 2.15B 2.02B 1.81B
Revenue Actual 2.45B 2.19B 2.14B 1.89B

To track all earnings releases for Williams-Sonoma visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And ‘Substantial Growth’

Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) announced on Tuesday its first quarter financial results for the three months ended March 31, 2024. The Toronto-based company reported a total revenue of CA$16.4 million ($12 million) (net revenue of CA$12.7 million, before excise duties and discounts), representing a 9% year-over-year increase. "Entourage's first quarter results are a testament to our robust financial health and strategic approach to business operations, positioning us for success throughout 2024," George Scorsis, the company's chair and CEO, said. "With defined infrastructure and supply agreements in place, we are well-positioned to continue delivering the accelerated growth we have already seen develop in Q1."

ETRGF